Literature DB >> 25227423

N-linked glycans on influenza A H3N2 hemagglutinin constrain binding of host antibodies, but shielding is limited.

Kevin Pentiah1, William D Lees1, David S Moss1, Adrian J Shepherd2.   

Abstract

The extent of the role of N-linked glycans (N-glycans) in shielding influenza A hemagglutinin (HA) against host antibodies has proved controversial, with different authors making widely different assumptions. One common assumption is that N-glycans physically shield surface residues that are near to glycosylation sites, thereby preventing antibodies from binding to them. However, it is unclear, from existing experimental evidence, whether antibodies that bind close to N-glycans are a rare or commonplace feature of human herd immune responses to influenza AHA. The aim of this paper is to present a computational analysis of mutations in the vicinity of N-glycans that will facilitate a better understanding of their protective role. We identify, from an analysis of over 6000 influenza A H3N2 sequences, a set of residues adjacent to N-glycosylation sites that are highly likely to be involved in antigenic escape from host antibodies. Fifteen of these residues occur within 10 Å of an N-glycosylation site. Hence, we conclude that it is relatively common for antibodies to bind in close proximity to N-glycans on the surface ofHA, with any shielding effect largely attributable to the inability of host antibodies to bind across an N-glycan attachment site, rather than to the physical masking of neighboring residues.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  N-glycans; bioinformatics; hemagglutinin; influenza A

Mesh:

Substances:

Year:  2014        PMID: 25227423     DOI: 10.1093/glycob/cwu097

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  9 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

Review 2.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

3.  N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.

Authors:  Ying Huang; Simon O Owino; Corey J Crevar; Donald M Carter; Ted M Ross
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

5.  N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.

Authors:  Yanming An; Lisa M Parsons; Ewa Jankowska; Darya Melnyk; Manju Joshi; John F Cipollo
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.

Authors:  Zhong-Zhou Huang; Liang Yu; Ping Huang; Li-Jun Liang; Qing Guo
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

7.  Virological Surveillance of Influenza A Subtypes Isolated in 2014 from Clinical Outbreaks in Canadian Swine.

Authors:  Helena Grgić; Jackie Gallant; Zvonimir Poljak
Journal:  Viruses       Date:  2017-03-21       Impact factor: 5.048

8.  Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.

Authors:  Amanda L Skarlupka; Simon O Owino; Lui P Suzuki-Williams; Corey J Crevar; Donald M Carter; Ted M Ross
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

9.  N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.

Authors:  Muhammed Iraqi; Avishay Edri; Yariv Greenshpan; Kiran Kundu; Priyanka Bolel; Avishag Cahana; Aner Ottolenghi; Roi Gazit; Leslie Lobel; Alex Braiman; Angel Porgador
Journal:  Front Cell Infect Microbiol       Date:  2020-03-06       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.